|
Phone: +1 610 454-8000 |
Address:
500 Arcola Road
Collegeville, PENNSYLVANIA 19426 |
Company Description
Rhone-Poulenc Rorer Inc is a publicly traded, global pharmaceutical company dedicated to the discovery, development and marketing of human pharmaceuticals. Two-thirds of the RPR shares are owned by Rhone-Poulenc S.A. which is structured around several closely related core competencies: life sciences, applied chemistry, specialty chemicals and chemical intermediates. RPR operates in all major markets of the world.
Key People
| Chairman & Chief Executive | M. DE ROSEN |
| SR VP & Chief Financial | P. LANGLOIS |
| Treasurer | J. BOND |
Related Business Topics
Breaking News
Reuters - November 18, 2009 7:28 AM
TORONTO, Nov. 18 /PRNewswire-FirstCall/ - Patheon, Inc. (TSX: PTI), a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that it has named Francisco R. Negron as Vice President and ...
Forbes.com - November 10, 2009 6:39 AM
BusinessWire - Fero Industries, Inc. (OTCBB: FROI) (the "Company") is pleased to announce to the appointment of Robert C. Moellering, Jr., M.D. as Chairman of the Scientific Advisory Board of Pyro Pharmaceuticals, Inc. As previously announced, the ...
Reuters - November 05, 2009 2:27 PM
CEDAR KNOLLS, N.J.--(Business Wire)-- Emisphere Technologies, Inc. (OTC BB:EMIS) today announced that Tim Rothwell, former Chairman of Sanofi-aventis U.S., has been appointed to the Company's Board of Directors effective immediately. Mr. Rothwell's ...
